Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-27

Clinical Trial Update: Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes [NA]

View source ↗

Summary

The trial evaluated continuous subcutaneous insulin infusion versus multiple daily injections to reach HbA1c targets in children and adolescents with Type 1 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 1 | NA | Status: COMPLETED